176 related articles for article (PubMed ID: 32835874)
1. Early high-dose intravenous corticosteroids rapidly arrest Stevens Johnson syndrome and drug reaction with eosinophilia and systemic symptoms recurrence on drug re-exposure.
Lehloenya RJ; Isaacs T; Nyika T; Dhana A; Knight L; Veenstra S; Peter J
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):582-584.e1. PubMed ID: 32835874
[No Abstract] [Full Text] [Related]
2. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome.
Bohm KJ; Ciralsky JB; Harp JL; Bajaj S; Sippel KC
Cornea; 2016 Jun; 35(6):888-91. PubMed ID: 27078005
[TBL] [Abstract][Full Text] [Related]
3. Drug reaction with eosinophilia and systemic symptoms with features resembling Stevens-Johnson syndrome/toxic epidermal necrolysis related to apalutamide.
Hsu YO; Hsieh TS; Huang PW; Chu CY
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):e246-e248. PubMed ID: 36223304
[No Abstract] [Full Text] [Related]
4. A case of drug reaction with eosinophilia and systemic symptoms induced by ethambutol with early features resembling Stevens-Johnson syndrome.
Kim JY; Sohn KH; Song WJ; Kang HR
Acta Derm Venereol; 2013 Nov; 93(6):753-4. PubMed ID: 23584150
[No Abstract] [Full Text] [Related]
5. Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS).
Belver MT; Michavila A; Bobolea I; Feito M; Bellón T; Quirce S
Allergol Immunopathol (Madr); 2016; 44(1):83-95. PubMed ID: 26089185
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions.
Lee T; Lee YS; Yoon SY; Kim S; Bae YJ; Kwon HS; Cho YS; Moon HB; Kim TB
J Am Acad Dermatol; 2013 Sep; 69(3):407-15. PubMed ID: 23632341
[TBL] [Abstract][Full Text] [Related]
7. Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis).
Owen CE; Jones JM
Med Clin North Am; 2021 Jul; 105(4):577-597. PubMed ID: 34059239
[TBL] [Abstract][Full Text] [Related]
8. Differential expression profile of Th1/Th2-associated chemokines characterizes Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) as distinct entities.
Miyagawa F; Hasegawa A; Imoto K; Ogawa K; Kobayashi N; Ito K; Fujita H; Aihara M; Watanabe H; Sueki H; Tohyama M; Asada H
Eur J Dermatol; 2015; 25(1):87-9. PubMed ID: 25547780
[No Abstract] [Full Text] [Related]
9. [The major SCAR syndromes].
Piérard GE; Lesuisse M; Piérard-Franchimont C
Rev Med Liege; 2017 Oct; 72(10):444-447. PubMed ID: 29058836
[TBL] [Abstract][Full Text] [Related]
10. A study of severe cutaneous adverse reactions to drugs with special reference to treatment outcome.
Devi K; George S; Narayanan B
Indian J Dermatol Venereol Leprol; 2016; 82(2):239. PubMed ID: 26924413
[No Abstract] [Full Text] [Related]
11. Drug allergy and non-HIV immune reconstitution inflammatory syndrome.
Sueki H; Watanabe Y; Sugiyama S; Mizukawa Y
Allergol Int; 2022 Apr; 71(2):185-192. PubMed ID: 35236619
[TBL] [Abstract][Full Text] [Related]
12. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS.
Darlenski R; Kazandjieva J; Tsankov N
Clin Dermatol; 2015; 33(5):538-41. PubMed ID: 26321400
[TBL] [Abstract][Full Text] [Related]
13. Is steroid pulse therapy a suitable treatment for drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms? A systematic review of case reports in patients treated with corticosteroids in Japan.
Hashizume H; Ishikawa Y; Ajima S
J Dermatol; 2022 Feb; 49(2):303-307. PubMed ID: 34755354
[TBL] [Abstract][Full Text] [Related]
14. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Cardones AR
Clin Dermatol; 2020; 38(6):702-711. PubMed ID: 33341203
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis.
Patterson R; Miller M; Kaplan M; Doan T; Brown J; Detjen P; Grammer LC; Greenberger PA; Hogan MB; Latall J
Ann Allergy; 1994 Jul; 73(1):27-34. PubMed ID: 8030799
[TBL] [Abstract][Full Text] [Related]
17. Stevens-Johnson syndrome.
Araujo OE; Flowers FP
J Emerg Med; 1984; 2(2):129-35. PubMed ID: 6396327
[TBL] [Abstract][Full Text] [Related]
18. Drug Rash with eosinophilia and systemic symptoms versus Stevens-Johnson Syndrome--a case that indicates a stumbling block in the current classification.
Wolf R; Davidovici B; Matz H; Mahlab K; Orion E; Sthoeger ZM
Int Arch Allergy Immunol; 2006; 141(3):308-10. PubMed ID: 16940741
[TBL] [Abstract][Full Text] [Related]
19. Drug Reaction, Eosinophilia and Systemic Symptoms (DRESS) syndrome secondary to allopurinol with early lymphadenopathy and symptom relapse.
Turney R; Skittrall JP; Donovan J; Agranoff D
BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26438678
[TBL] [Abstract][Full Text] [Related]
20. [CME. Severe cutaneous drug reaction].
Deuel J; Schaer D; Schmid-Grendelmeier P; Vallelian F
Praxis (Bern 1994); 2014 Oct; 103(21):1231-43. PubMed ID: 25305114
[No Abstract] [Full Text] [Related]
[Next] [New Search]
